32
Participants
Start Date
June 13, 2017
Primary Completion Date
September 20, 2017
Study Completion Date
September 20, 2017
VFI
The IV administered visible fluorescent injectate (VFI)™ agent is comprised of a mixture of 2 different molecular weight carboxymethyl dextran molecules (5 kD and 150 kD) with different fluorescent dye molecules attached.
Iohexol
Iohexol is a contrast enhancement agent which, following intravascular injection, is distributed in the extracellular fluid compartment and is excreted unchanged by glomerular filtration.
University of Alabama Birmingham, Division of Nephrology, Birmingham
ICON Early Phase Services, LLC, San Antonio
Lead Sponsor
National Institutes of Health (NIH)
NIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
FAST BioMedical
INDUSTRY